Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Immunologic Research|January 1, 1995
The role of CD4+ tumor-infiltrating lymphocytes in human solid tumorsP S Goedegebuure, T J EberleinSurgery|August 1, 1997
Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cellsM Peiper, P S Goedegebuure, T J EberleinAnnals of Surgical Oncology|March 1, 1996
Vaccine therapy for cancerD C Linehan, P S Goedegebuure, T J EberleinZentralblatt Fur Chirurgie|January 1, 1997
[Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?"]M Peiper, P S Goedegebuure, T J Eberlein, et al.Anticancer Research|September 2, 1999
Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neuM Peiper, P S Goedegebuure, J R Izbicki, et al.Annals of Surgical Oncology|November 1, 1995
Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumorsY L Matory, M Chen, P S Goedegebuure, et al.Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003
[Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes]M Peiper, P S Goedegebuure, T J Eberlein, et al.Surgery|April 1, 1995
Immunoregulatory effects of CD4+ T helper subsets in human melanomaK Y Lee, P S Goedegebuure, D C Linehan, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancerI Yoshino, G E Peoples, P S Goedegebuure, et al.International Journal of Cancer|February 6, 1999
Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cellsM Nagoshi, N Sadanaga, H G Joo, et al.Pageof 5